Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BlackSky Technology Inc.BKSY · Entity 5048 | 10% owner | September 09, 2021 | September 20, 2021 |
| FRACTYL HEALTH, INC.GUTS · Entity 6700 | Director | June 12, 2026 | June 15, 2026 |
| Invivyd, Inc.IVVD · Entity 721 | Director | May 19, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BlackSky Technology Inc.
Report date September 09, 2021 · Filed September 20, 2021
Jointly reported with Mithril GP LP, Mithril LP, Mithril II UGP LLC, Mithril II GP LP, MITHRIL II LP, THIEL PETER
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 10,386,626 |
Reported balance
Holding disclosure · report date 2021-09-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 10,386,626 F1: Reflects shares of Class A common stock, par value $0.0001, of BlackSky Technology Inc., f/k/a Osprey Technology Acquisition Corp. (the "Issuer"), acquired on September 9, 2021, upon the completion of the merger (the "Business Combination") pursuant to the Agreement and Plan of Merger, dated as of February 17, 2021, by and among the Issuer, Osprey Technology Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Osprey Technology Acquisition Corp., and BlackSky Holdings, Inc., a Delaware corporation. F2: These shares are held of record by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP. Ajay Royan ("Royan") is the authorized person of GP LP and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by LP. Royan and Peter Thiel ("Thiel") are the members of the investment committee of GP LP. The investment committee makes all investment decisions with respect to shares held by LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of GP LP, Royan and Thiel disclaims beneficial ownership of the shares held by LP, except to the extent of their respective pecuniary interests therein, if any. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 8,241,400 |
Reported balance
Holding disclosure · report date 2021-09-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 8,241,400 F1: Reflects shares of Class A common stock, par value $0.0001, of BlackSky Technology Inc., f/k/a Osprey Technology Acquisition Corp. (the "Issuer"), acquired on September 9, 2021, upon the completion of the merger (the "Business Combination") pursuant to the Agreement and Plan of Merger, dated as of February 17, 2021, by and among the Issuer, Osprey Technology Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Osprey Technology Acquisition Corp., and BlackSky Holdings, Inc., a Delaware corporation. F3: Represents 7,741,400 shares of the Issuer's Class A common stock received in connection with the Business Combination and 500,000 shares of the Issuer's Class A common stock that were acquired in a private placement which closed concurrently with the Business Combination. F4: These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. Royan is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. Royan and Thiel are the members of the investment committee established by GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of UGP II, GP II, Royan and Thiel disclaims beneficial ownership of the shares held by II LP, except to the extent of their respective pecuniary interests therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of Class A common stock, par value $0.0001, of BlackSky Technology Inc., f/k/a Osprey Technology Acquisition Corp. (the "Issuer"), acquired on September 9, 2021, upon the completion of the merger (the "Business Combination") pursuant to the Agreement and Plan of Merger, dated as of February 17, 2021, by and among the Issuer, Osprey Technology Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Osprey Technology Acquisition Corp., and BlackSky Holdings, Inc., a Delaware corporation.
F2: These shares are held of record by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP. Ajay Royan ("Royan") is the authorized person of GP LP and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by LP. Royan and Peter Thiel ("Thiel") are the members of the investment committee of GP LP. The investment committee makes all investment decisions with respect to shares held by LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of GP LP, Royan and Thiel disclaims beneficial ownership of the shares held by LP, except to the extent of their respective pecuniary interests therein, if any.
F3: Represents 7,741,400 shares of the Issuer's Class A common stock received in connection with the Business Combination and 500,000 shares of the Issuer's Class A common stock that were acquired in a private placement which closed concurrently with the Business Combination.
F4: These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. Royan is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. Royan and Thiel are the members of the investment committee established by GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of UGP II, GP II, Royan and Thiel disclaims beneficial ownership of the shares held by II LP, except to the extent of their respective pecuniary interests therein, if any.
FRACTYL HEALTH, INC.
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,901 |
Reported balance
After 2026-06-12 transaction · row 1
1 source rowRow 1 · 2026-06-12 · Purchase · Acquired 23,000 · Balance 40,901 F1: Open market purchase. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 5,160,301 |
Reported balance
Holding disclosure · report date 2026-06-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,160,301 F2: Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,251,900 |
Reported balance
Holding disclosure · report date 2026-06-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,251,900 F3: Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Open market purchase.
F2: Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
F3: Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
Invivyd, Inc.
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.04 · Expires 2036-05-18 | Direct | 50,000 |
Reported balance
After 2026-05-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 50,000 · Balance 50,000 F1: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2026 Filed Jun 15, 2026 22:06 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | PurchaseCommon Stock | 23,000 | $0.85 | $19,596.00 |
DisclosureSEC source: 0001193125-26-271386 · ownership.xml · nonDerivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,901 F1 · kind: Open market purchase. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 21:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 22,500 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001193125-26-267847 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2036-06-09 F1 · derivative.exercise_date: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:49 UTC | Invivyd, Inc. IVVD · Entity 721 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001193125-26-234666 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-05-18 F1 · derivative.exercise_date: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:05 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 22,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0000950170-25-086144 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2035-06-10 F1 · derivative.exercise_date: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:06 UTC | Invivyd, Inc. IVVD · Entity 721 | GrantStock Option (Right to Buy) · Derivative | 8,219 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000950170-25-076305 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,219 Underlying: Common Stock · 8,219 shares Expires 2035-05-19 F1 · derivative.exercise_date: This option was granted on May 20, 2025 and vests in full upon the earlier of (i) May 20, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 21:28 UTC | Invivyd, Inc. IVVD · Entity 721 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0000950170-25-045465 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-03-23 F1 · derivative.exercise_date: This option was granted on March 24, 2025 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 23:57 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | PurchaseCommon Stock | 17,901 | $1.28 | $22,979.51 |
DisclosureSEC source: 0000950170-25-041633 · ownership.xml · nonDerivative · entry 1 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.22 to 1.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries F Preferred Stock · Derivative | 1,598,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · derivative · entry 8 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 744,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F3 · ownership.nature: Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries E Preferred Stock · Derivative | 373,021 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · derivative · entry 7 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 173,821 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F3 · ownership.nature: Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries D Preferred Stock · Derivative | 545,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · derivative · entry 6 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 254,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F2 · ownership.nature: Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries C-2 Preferred Stock · Derivative | 6,502,796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · derivative · entry 5 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 3,030,193 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F2 · ownership.nature: Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries C-1 Preferred Stock · Derivative | 4,025,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · derivative · entry 4 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,875,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F2 · ownership.nature: Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | PurchaseCommon Stock | 333,333 | $15.00 | $4,999,995.00 |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · nonDerivative · entry 3 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,251,900 F3 · ownership.nature: Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionCommon Stock | 918,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · nonDerivative · entry 2 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 918,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F3 · ownership.nature: Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionCommon Stock | 5,160,301 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012838 · ownership.xml · nonDerivative · entry 1 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,160,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock. F2 · ownership.nature: Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 22:11 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 45,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011341 · ownership.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock option vests in three annual installments beginning on February 1, 2025. Read SEC document |
| August 10, 2021 Filed Aug 13, 2021 01:27 UTC | Invivyd, Inc. ADGI · Entity 721 | ConversionSeries C Preferred Stock · Derivative | 422,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051299 · doc4.xml · derivative · entry 5 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 2,113,060 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F2 · ownership.nature: These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. The Reporting Person is one of two members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The Reporting Person disclaims beneficial ownership of the shares held by II LP, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document |
| August 10, 2021 Filed Aug 13, 2021 01:27 UTC | Invivyd, Inc. ADGI · Entity 721 | ConversionSeries B Preferred Stock · Derivative | 176,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051299 · doc4.xml · derivative · entry 4 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 881,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F2 · ownership.nature: These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. The Reporting Person is one of two members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The Reporting Person disclaims beneficial ownership of the shares held by II LP, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document |
| August 10, 2021 Filed Aug 13, 2021 01:27 UTC | Invivyd, Inc. ADGI · Entity 721 | ConversionSeries A Preferred Stock · Derivative | 1,250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051299 · doc4.xml · derivative · entry 3 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 6,250,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F2 · ownership.nature: These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. The Reporting Person is one of two members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The Reporting Person disclaims beneficial ownership of the shares held by II LP, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document |
| August 10, 2021 Filed Aug 13, 2021 01:27 UTC | Invivyd, Inc. ADGI · Entity 721 | PurchaseCommon Stock | 1,997,000 | $17.00 | $33,949,000.00 |
DisclosureSEC source: 0001209191-21-051299 · doc4.xml · nonDerivative · entry 2 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 11,241,580 F2 · ownership.nature: These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. The Reporting Person is one of two members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The Reporting Person disclaims beneficial ownership of the shares held by II LP, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document |
| August 10, 2021 Filed Aug 13, 2021 01:27 UTC | Invivyd, Inc. ADGI · Entity 721 | ConversionCommon Stock | 9,244,580 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-051299 · doc4.xml · nonDerivative · entry 1 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,244,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. F2 · ownership.nature: These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. The Reporting Person is one of two members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The Reporting Person disclaims beneficial ownership of the shares held by II LP, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 23:56 UTC | Invivyd, Inc. ADGI · Entity 721 | GrantStock Option (Right to Buy) · Derivative | 35,593 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-21-050490 · doc4.xml · derivative · entry 1 Royan Ajay · CIK 0001875614 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,593 Underlying: Common Stock · 35,593 shares Expires 2031-08-04 F1 · derivative.exercise_date: One third (1/3) of the option shall vest on August 5, 2022, and thereafter, the remainder of the option shall vest in 24 equal monthly installments on the 5th day of each month, subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.